Company Filing History:
Years Active: 1997-1998
Title: Avram Brickner: Innovator in Biocompatible Polymer Compositions
Introduction
Avram Brickner is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of biocompatible polymers, particularly in the development of compositions for the sustained release of erythropoietin (EPO). With a total of 2 patents, Brickner's work is paving the way for advancements in therapeutic applications.
Latest Patents
One of Brickner's latest patents focuses on a composition for the sustained release of non-aggregated, biologically active erythropoietin. This innovative composition comprises a polymeric matrix made from a biocompatible polymer and particles of aggregation-stabilized EPO. The method for producing this composition involves dissolving the biocompatible polymer in a solvent, dispersing the EPO particles, and solidifying the polymer to create a matrix that effectively releases EPO over time. This method aims to provide a therapeutically effective blood level of EPO in subjects for an extended period.
Career Highlights
Avram Brickner is currently associated with Alkermes, Inc., where he continues to develop innovative solutions in the field of biopharmaceuticals. His work is instrumental in enhancing the efficacy of treatments that rely on erythropoietin, which is crucial for managing conditions related to anemia.
Collaborations
Brickner has collaborated with notable colleagues such as Stephen E Zale and Paul A Burke. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Avram Brickner's contributions to the field of biocompatible polymers and erythropoietin release compositions highlight his role as an influential inventor. His work not only showcases innovation but also has the potential to significantly impact therapeutic practices in medicine.